Innoviva Inc (INVA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access INVA quarterly Cash Flow →
Cash flow data covering Innoviva Inc–Dec 31 2021 offers a view into how Dec 31 2025's cash position has developed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income271.17
Depreciation & amortization0.00
Amortization of Other Assets28.16
Increase (Decrease) in Deferred Revenue3.14
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-12.92
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation9.45
Income (Loss) from Equity Method Investments-141.43
Gains (Losses) on Extinguishment of Debt0.00
Other Than Temporary Impairment Losses Investments Availableforsale Securities-
Investment Income Amortization Of Premium-
Investment Income Net Amortization Of Discount And Premium-
Interest Costs Capitalized-
Gain Loss On Repurchase Of Convertible Subordinated Notes-
Marketable Securities Realized Gain Loss-
Amortization Of Capitalized Fees And Depreciation Of Property And Equipment13.95
Fair Value Adjustments Included In Cost Of Product Sales-
Inventory Fair Value Step Up Adjustment Included In Cost Of Product Sales4.84
Deconsolidation Gain Or Loss Amount-
Unrealized Other Gain Loss On Investments-20.16
Acquired In- Process Research And Development Assets9.37
Income taxes47.91
Proceeds from (Payments for) Trading Securities, Short-term8.43
Accounts Receivable-6.95
Increase (Decrease) in Accounts Payable2.83
Accrued Expense-7.59
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-5.66
Other Working Capital-1.08
Other Noncash Income (Expense)1.90
Other net0.00
Payments for (Proceeds from) Other Operating Activities-8.43
Discontinued operations0.00
Net Cash flow from Operating Activities196.93
Investing Activities
Capital Expenditures-1.13
Sale of Capital Items0.01
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities-60.90
Real Estate Investments0.00
Payments For Capitalized Fees Paid To Related Party-
Distributions Of Equity And Long Term Investments-
Sale Of Equity Investments Managed By Isp Fund Lp28.16
Purchase And Sale Of Other Investments Managed By Isp Fund Lp92.79
Net Proceeds From Sale Of Variable Interest Entity Equity-
Cash Paid For The Acquisition Of La Jolla Pharmaceutical Company Net Of Cash Acquired-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments-17.50
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development-9.37
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net8.43
Discontinued operations0.00
Net Cash Flow from Investing Activities40.50
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock8.72
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.17
Payments For Repurchase Of Convertible Subordinated Notes-
Repayments Of Non Recourse Notes Principal-
Payments Of Principal On Senior Secured Term Loans-
Net Proceeds From Issuance Of Variable Interest Entity S Equity-
Net Proceeds From Issuance Of Variable Interest Entity Equity-
Purchases Of Capped Call Options Associated With Convertible Senior Notes-
Purchase Of Entasis Noncontrolling Interest-
Non Cash Activity-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities8.55
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow195.81
Total Cash Flow245.98
4 historic quarters locked

Sign in to unlock the full Innoviva Inc cash flow history.

About Innoviva Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: inva-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-071776

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License